Living Cell Technologies Limited (LCT) 2023年年度报告「ASX」.pdf

《Living Cell Technologies Limited (LCT) 2023年年度报告「ASX」.pdf》由会员分享，可在线阅读，更多相关《Living Cell Technologies Limited (LCT) 2023年年度报告「ASX」.pdf（51页珍藏版）》请在三个皮匠报告上搜索。

1、Living Cell Technologies Limited ABN:104 028 042 Appendix 4E full year ended 30 June 2023(Previous corresponding period:Year ended 30 June 2022)Results for Announcement to Market 2023 2022$Services revenue -Total other income 42,016 3,405 Total revenue and other income 42,016 3,405(2,107,658)(2,372,

2、029)Loss before income tax expense Income tax credit-414,729Reported net loss after tax attributable to members of the parent entity (2,107,658)(1,957,300)Reported Total revenue and other income increased 1,134%to$42,016.Net loss from ordinary activities attributable to members of the parent entity

3、hasdecreased to$2,107,658.Net loss after tax for the year attributable to members of the parent entity hasincreased to$2,107,658.Dividends Amount per security Franked amount per security Final dividend NIL-Previous corresponding period NIL-Record date for determining entitlements to the dividend:n/a

4、 Date the dividend is payable n/a Explanation of results For further explanation of the results please refer to the ASX release.Other information required by Listing Rule 4.3A The remainder of the information requiring disclosure to comply with Listing Rule 4.3A is contained in the attached Consolid

5、ated Financial Report and media release.Additional Information NTA Backing 30 June 2023 30 June 2022 Net tangible asset backing per ordinary share 0.2 cents per share 0.3 cents per share Changes in controlled entities No companies were acquired during the year.One company was disposed of during the

6、year.Audit Report The audit report is contained in the attached Financial Report.M Bhalla Company Secretary 30 August 2023 Living Cell Technologies Limited Consolidated financial statements For the Year Ended 30 June 2023 Living Cell Technologies Limited Contents For the year ended 30 June 2023 Page